Cooper-Standard Holdings Inc. quarterly report, Q3 FY2012

Cooper-Standard Holdings Inc. — Form 10-Q Summary

Period: Quarter and nine months ended September 30, 2012; filed November 8, 2012. The filing states the financial statements are unaudited. Metadata discrepancy: The request identifies “2011 Q3,” but the supplied filing covers 2012 Q3 and compares against 2011.

Business context and results

The company manufactures fluid-handling, body-sealing and anti-vibration products, primarily for global automotive OEMs and replacement markets. It reports North America and International segments. Unless stated otherwise, amounts below are in millions of U.S. dollars.

MetricQ3 2012Q3 2011Nine months 2012Nine months 2011
Sales$684.0$708.5$2,183.8$2,157.8
Gross profit / margin$103.1 / 15.1%$108.6 / 15.3%$339.2 / 15.5%$353.0 / 16.4%
Operating profit$23.6$33.7$105.4$102.3
Income before taxes$15.8$16.1$77.5$81.8
Net income attributable to Cooper-Standard Holdings$11.6$15.7$112.7$79.6
Diluted earnings per share$0.44$0.58$4.63$3.08

Cash flow, debt and liquidity

  • Cash from operating activities was negative $22.0 million for the first nine months of 2012, versus positive $45.8 million in 2011. The company cited $187.4 million of cash use from changes in operating assets and liabilities, including a $110.6 million increase in receivables, and $29.8 million of pension contributions.
  • Investing cash use was $83.6 million, including $91.5 million in capital expenditures. Financing cash use was $37.8 million, including $20.6 million of common-stock repurchases, $4.9 million of preferred-stock repurchases, debt payments and dividends.
  • Cash declined from $361.7 million at year-end 2011 to $217.8 million at September 30, 2012. Total debt was $482.2 million, including $450.0 million of senior notes; debt was down from $488.7 million at year-end. No borrowings were outstanding under the $125 million Senior ABL Facility, though $27.6 million of letters of credit were outstanding.
  • Current assets were $998.6 million and current liabilities $461.2 million at September 30. Management said cash, operating cash flow and ABL availability were expected to meet working-capital, capital-spending and debt-service needs for the next 12 months and foreseeable future, subject to operating performance, market conditions and facility covenants.

Material changes and management commentary

  • Q3 sales fell 3.5%, primarily from $42.5 million of unfavorable foreign exchange and lower International volumes, partly offset by North American growth. Nine-month sales rose 1.2%, with North American volumes and the USi and FMEA transactions offsetting foreign exchange and lower International volumes.
  • North American Q3 sales increased 4.4%; International sales declined 11.1%. For nine months, North American segment profit fell to $113.9 million from $131.9 million, while the International segment loss narrowed to $36.4 million from $50.1 million.
  • Gross margin declined year over year for both periods. Management cited higher material costs, launch and expansion expenses, unfavorable currency effects and lower margins at acquired businesses; lean savings and North American volumes partly offset these pressures. Nine-month selling, administration and engineering costs increased to $206.4 million from $190.9 million.
  • Nine-month attributable earnings benefited substantially from a $32.8 million income-tax benefit. The company reversed its U.S. deferred-tax valuation allowance after reaching a three-year cumulative income position; it expected approximately $67.8 million of 2012 tax benefits related to U.S. valuation-allowance reductions. The reported nine-month effective tax rate was negative 42%; excluding the discrete release, it was 20%.
  • Management expected 2012 capital expenditures of approximately $120 million to $130 million. It cited IHS Automotive forecasts of 2012 light-vehicle production of 15.1 million units in North America and 19 million in Europe. Fourth-quarter production was estimated at 3.6 million North American and 4.5 million European units.
  • The company said it had maintained customer supply despite a supplier chemical-plant shutdown affecting PA-12 resin, and anticipated supply normalization in Q4 2012. It warned that a fourth-quarter goodwill impairment charge of up to $2.9 million might be recorded for its South America reporting unit.

Restructuring, risks and other notable items

  • Q3 restructuring expense was $10.2 million; nine-month expense was $15.8 million, down from $48.1 million in the comparable 2011 period. A European footprint initiative was estimated to cost $20.3 million and was expected to be completed in 2013.
  • The FMEA joint venture’s noncontrolling shareholders can put their remaining interest to the company after the specified four-year period. The estimated redemption value was $28.9 million at September 30, 2012; the obligation is guaranteed by the company.
  • Key disclosed risks include automotive production and customer concentration, pricing and raw-material pressures, foreign exchange, international operations, labor and pension costs, execution of restructuring and acquisitions, liquidity and debt covenants, and possible goodwill or intangible-asset impairment. Ordinary-course legal and environmental matters were disclosed; management did not expect their resolution to materially adversely affect results, while noting uncertainty.
  • Jeffrey S. Edwards was appointed CEO effective October 15, 2012, succeeding James S. McElya, who was expected to remain as non-executive chairman. Management reported disclosure controls were effective.

Important facts for investors to verify

  • Whether operating cash flow recovers as receivables and other working-capital balances normalize.
  • Whether the expected U.S. tax benefits are realized and how much of reported earnings reflects the valuation-allowance reversal.
  • Progress on European restructuring, its remaining cash costs, and profitability of the International segment and acquired operations.
  • Actual 2012 capital spending, automotive production trends, PA-12 supply normalization, and whether the potential South America impairment is recorded.
  • Available borrowing capacity under the ABL after borrowing-base limits and letters of credit, along with compliance with debt covenants and the FMEA put obligation.